Valproate prevents MK801-induced changes in brain-derived neurotrophic factor mRNA in the rat brain

Eur J Pharmacol. 2006 Sep 18;545(2-3):142-6. doi: 10.1016/j.ejphar.2006.06.046. Epub 2006 Jun 28.

Abstract

To investigate whether the anticonvulsant valproate influences the changes in brain-derived neurotrophic factor (BDNF) mRNA expression induced by MK801 in rat brain, we injected valproate prior to MK801 and observed the changes in the BDNF expression 3 h later. MK801 significantly increased BDNF expression in the retrosplenial and entorhinal cortex, and these increases were prevented by valproate pretreatment. Valproate pretreatment significantly blocked the MK801-induced increase of BDNF expression in retrosplenial cortex at 3 h, 6 h, and 9 h after MK801 injection, suggesting that valproate pretreatment did not delay the MK801-induced increase of BDNF expression. However, MK801 significantly decreased BDNF expression in the granule cell layer of hippocampus, and valproate pretreatment before MK801 potentiated the MK801-induced decrease in BDNF expression in granule cell layer. These results indicate that valproate pretreatment differentially affects the MK801-induced changes in BDNF expression in a region-selective manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology*
  • Brain / drug effects*
  • Brain / metabolism
  • Brain-Derived Neurotrophic Factor / genetics*
  • Dizocilpine Maleate / pharmacology*
  • Male
  • RNA, Messenger / analysis*
  • Rats
  • Rats, Sprague-Dawley
  • Valproic Acid / pharmacology*

Substances

  • Anticonvulsants
  • Brain-Derived Neurotrophic Factor
  • RNA, Messenger
  • Valproic Acid
  • Dizocilpine Maleate